Quick Answer
Barinthus Biotherapeutics plc. reported Total Assets of $98.17 million for fiscal year 2025.
Barinthus Biotherapeutics plc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $98.17M | -38.8% |
| 2024 | $160.33M | -25.3% |
| 2023 | $214.51M | -20.6% |
| 2022 | $270.20M | -3.7% |
| 2021 | $280.71M | +454.1% |
| 2020 | $50.67M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $109.20M | -42.1% | -15.7% |
| June 30, 2025 | $129.56M | -30.6% | -8.8% |
| March 31, 2025 | $142.00M | -28.8% | -11.4% |
| December 31, 2024 | $160.33M | -25.3% | -15.0% |
| September 30, 2024 | $188.69M | -18.0% | +1.0% |
| June 30, 2024 | $186.75M | -24.1% | -6.4% |
| March 31, 2024 | $199.48M | -23.8% | -7.0% |
| December 31, 2023 | $214.51M | -20.6% | -6.7% |
- Barinthus Biotherapeutics plc. showed a decrease of -38.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Barinthus Biotherapeutics plc.’s total assets has grown by 93.8% (from $50.67 million to $98.17 million).
- The most recent figure is from Barinthus Biotherapeutics plc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: